Didier is a highly experienced investor and esteemed figure in the Canadian life sciences sector. Didier has played a pivotal role in collaborating with entrepreneurs and funds to drive the life science sector forward as Vice-President, Life Science & Technology for Investissement Quebec and Vice-President Life Sciences and Funds-of-Funds at Fonds de solidarite FTQ.
Prior to that, he was actively involved in technology transfer and managed a seed investment fund affiliated with renowned universities.
Didier holds a MBA, Technology Management & Innovation from the Universite du Quebec a Montreal, a certification in governance from Universite Laval and an engineering degree in Material sciences from Ecole d’ingenieurs Sup Galilee, Institut Galilee, Universite Sorbonne Paris Nord.
He sits on the Board of Directors of Congruence Therapeutics, DalCor Pharmaceutical, Morphocell Technologies, and the Institut de Recherche Clinique de Montreal. He also helps several clients in the life sciences and investment sector as an advisor and strategist.
